Showing results (91-100 of 141) with videos related to
Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolyticsZong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.Cancer Immunology Research|May 5, 2017
Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell DeathLazar Vujanovic, Elizabeth C Stahl, Angela D Pardee, et al.Human Immunology|August 23, 2005
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitroDominic E Warrino, Walter C Olson, Meera I Scarrow, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic miceXi Zhao, Anamika Bose, Hideo Komita, et al.Cancer Research|October 16, 2003
Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunityTomohide Tatsumi, Jian Huang, William E Gooding, et al.Journal of Biomedicine & Biotechnology|March 27, 2010
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patientsElisabetta Cavalcanti, Margherita Gigante, Vito Mancini, et al.Cancer Research|October 3, 2008
CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growthHideo Komita, Xi Zhao, Jennifer L Taylor, et al.International Immunology|August 31, 2002
Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class IIAnna E Lokshin, Pawel Kalinski, R Rita Sassi, et al.Oncoimmunology|May 6, 2015
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potencyYi Zhang, Shenghe Tian, Zuqiang Liu, et al.Journal of Translational Medicine|February 14, 2007
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor modelsXinmei Zhu, Fumihiko Nishimura, Kotaro Sasaki, et al.Pageof 15